UBS Group
NHC icon

UBS Group’s National Healthcare NHC Stock Holding History

UBS Group’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Buy
20,610
+13,157
+177% +$2.02M ﹤0.01% 4498
2025
Q4 		$1.02M Sell
7,453
-3,588
-32% -$463K ﹤0.01% 5557
2025
Q3 		$1.34M Buy
11,041
+1,495
+16% +$161K ﹤0.01% 5309
2025
Q2 		$1.02M Sell
9,546
-6,616
-41% -$661K ﹤0.01% 5441
2025
Q1 		$1.5M Sell
16,162
-323
-2% -$31.3K ﹤0.01% 4939
2024
Q4 		$1.77M Buy
16,485
+7,828
+90% +$952K ﹤0.01% 4834
2024
Q3 		$1.09M Buy
8,657
+2,739
+46% +$344K ﹤0.01% 4584
2024
Q2 		$642K Sell
5,918
-3,942
-40% -$384K ﹤0.01% 4800
2024
Q1 		$932K Sell
9,860
-3,582
-27% -$339K ﹤0.01% 4660
2023
Q4 		$1.24M Buy
13,442
+1,587
+13% +$122K ﹤0.01% 4313
2023
Q3 		$758K Buy
11,855
+1,002
+9% +$64.2K ﹤0.01% 4331
2023
Q2 		$671K Buy
10,853
+4,419
+69% +$262K ﹤0.01% 4566
2023
Q1 		$374K Buy
6,434
+3,127
+95% +$180K ﹤0.01% 4919
2022
Q4 		$197K Buy
3,307
+2,372
+254% +$144K ﹤0.01% 5466
2022
Q3 		$59K Sell
935
-568
-38% -$39.5K ﹤0.01% 6182
2022
Q2 		$105K Sell
1,503
-2,672
-64% -$187K ﹤0.01% 5395
2022
Q1 		$294K Sell
4,175
-4,996
-54% -$336K ﹤0.01% 5078
2021
Q4 		$622K Buy
9,171
+7,492
+446% +$518K ﹤0.01% 4804
2021
Q3 		$117K Sell
1,679
-325
-16% -$23.6K ﹤0.01% 5723
2021
Q2 		$140K Sell
2,004
-6,142
-75% -$446K ﹤0.01% 5619
2021
Q1 		$634K Buy
8,146
+2,098
+35% +$148K ﹤0.01% 4686
2020
Q4 		$402K Buy
6,048
+118
+2% +$7.77K ﹤0.01% 4775
2020
Q3 		$370K Sell
5,930
-2,397
-29% -$150K ﹤0.01% 4391
2020
Q2 		$529K Buy
8,327
+1,415
+20% +$94.9K ﹤0.01% 4078
2020
Q1 		$496K Sell
6,912
-7,360
-52% -$582K ﹤0.01% 3966
2019
Q4 		$1.23M Buy
14,272
+2,856
+25% +$239K ﹤0.01% 4007
2019
Q3 		$934K Buy
11,416
+7,384
+183% +$611K ﹤0.01% 4026
2019
Q2 		$327K Buy
4,032
+1,663
+70% +$128K ﹤0.01% 4589
2019
Q1 		$180K Sell
2,369
-4,821
-67% -$382K ﹤0.01% 4673
2018
Q4 		$564K Buy
7,190
+2,037
+40% +$159K ﹤0.01% 4167
2018
Q3 		$388K Buy
5,153
+1,911
+59% +$141K ﹤0.01% 4591
2018
Q2 		$229K Buy
3,242
+1,153
+55% +$75.4K ﹤0.01% 4845
2018
Q1 		$124K Buy
2,089
+289
+16% +$17.7K ﹤0.01% 5094
2017
Q4 		$110K Sell
1,800
-1,345
-43% -$85.8K ﹤0.01% 5286
2017
Q3 		$197K Buy
3,145
+917
+41% +$59.1K ﹤0.01% 4857
2017
Q2 		$156K Buy
2,228
+329
+17% +$23.5K ﹤0.01% 4905
2017
Q1 		$135K Sell
1,899
-1,101
-37% -$81.5K ﹤0.01% 4902
2016
Q4 		$227K Buy
3,000
+2,817
+1,539% +$195K ﹤0.01% 4706
2016
Q3 		$12K Hold
183
– – ﹤0.01% 6660
2016
Q2 		$12K Sell
183
-204,076
-100% -$13M ﹤0.01% 6682
2016
Q1 		$12.7M Buy
204,259
+203,880
+53,794% +$12.7M 0.01% 1166
2015
Q4 		$23K Sell
379
-1,136
-75% -$73.6K ﹤0.01% 6607
2015
Q3 		$92K Buy
1,515
+331
+28% +$20.7K ﹤0.01% 5300
2015
Q2 		$77K Buy
1,184
+894
+308% +$56.7K ﹤0.01% 5627
2015
Q1 		$18K Sell
290
-235
-45% -$14.9K ﹤0.01% 7078
2014
Q4 		$33K Buy
+525
New +$31.5K ﹤0.01% 7002

Other funds holding NHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's NHC Position: Q1 2026 in Review

UBS Group increased its National Healthcare (NHC) stake by 177% in Q1 2026, buying an estimated $2.02M and bringing the position to 20,610 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

UBS Group first reported a position in NHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $12.7M in Q1 2016. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • UBS Group held 20,610 shares of National Healthcare worth $3.29M as of Q1 2026.
  • UBS Group bought 13,157 National Healthcare shares in Q1 2026, an estimated $2.02M.
  • National Healthcare made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4498 holding.
  • UBS Group first reported a position in National Healthcare in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's National Healthcare position peaked at $12.7M in Q1 2016.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.